XPEV Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Based on the provided data, XPeng Inc. (XPEV) is not a strong buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. While the company has some positive catalysts, such as its expansion plans and technological advancements, the technical indicators, analyst sentiment, and financial performance suggest a cautious approach. Holding the stock or waiting for further clarity on its growth trajectory and market conditions is recommended.
The technical indicators for XPEV are bearish. The MACD is negatively expanding, RSI is neutral at 20.256, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below its pivot point of 17.217, with key support at 16.149 and resistance at 18.284.
XPeng is planning international expansion with new EV production facilities in Europe, Southeast Asia, and Latin America.
The company expects to start large-scale production of flying cars next year and has received over 7,000 orders.
XPeng is deepening its collaboration with Volkswagen on EV production and plans to launch humanoid robots in Q4 2026.
Increased competition in China from General Motors, Hyundai, and Volkswagen, all launching new EV models and features.
Analysts have downgraded the stock multiple times, citing weak near-term growth, higher spending, and uncertainty about new product success.
The company's financial performance shows a significant drop in net income (-129.21% YoY) and EPS (-118.75% YoY), despite revenue growth.
In Q4 2025, XPeng's revenue increased by 40.10% YoY to $3.14 billion, and gross margin improved by 47.58% YoY to 21.31%. However, net income dropped by -129.21% YoY to $54.05 million, and EPS fell by -118.75% YoY to $0.03, reflecting higher costs and weaker profitability.
Analyst sentiment is mixed to negative. Recent downgrades include BNP Paribas to Underperform and Macquarie to Neutral. Price targets have been lowered by multiple firms, with Barclays setting a target of $16 and Macquarie at $19. However, some analysts, like Citi, maintain a Buy rating with a $25.60 price target, citing potential for gross margin improvement and new model launches.
